Putting patients first: Retail pharmacies—and the patients they serve—are being endangered by PBM Power
This is the fourth in a series of Bio.News articles looking at the need for pharmacy benefit manager reform through the lens of the […]
This is the fourth in a series of Bio.News articles looking at the need for pharmacy benefit manager reform through the lens of the […]
This is the third in a series of Bio.News articles looking at the need for pharmacy benefit manager reform through the lens of the
Pictured above, Rep. Deborah Ross (D-NC) addresses the opening session of BIO’s Intellectual Property Counsels Committee Conference in Washington, D.C., on Nov. 18. The
BIO IP conference promotes protection of innovation Read More »
This is the second in a series of Bio.News articles looking at the need for pharmacy benefit manager reform through the lens of the
Putting patients first: Unchecked step therapy puts PBM profits ahead of patient care Read More »
This is the first in a series of Bio.News articles looking at the need for pharmacy benefit manager (PBM) reform through the lens of
Insurers and pharmacy benefit managers (PBMs) in search of profits are preventing patients from getting the drugs they need, according to the latest episode
How utilization management blocks patient access Read More »
The Biotechnology Innovation Organization (BIO) has once again requested that the Centers for Medicare & Medicaid Services (CMS) take steps to protect patient access,
CMS must address Part D plan abuse of IRA provisions designed to protect patient access Read More »
Despite frequent criticism of the Federal Trade Commission (FTC), the Conservative Political Action Conference (CPAC) has announced its support for FTC efforts to rein in pharmacy
CPAC supports FTC action against pharmacy benefit managers Read More »
October is the scariest time of year. Young goblins walk the streets demanding treats, local haunted houses are packed full of fright-chasing teens, and
Open enrollment can be a ‘House of Horrors’: 4 monsters for patients to beware Read More »
The 340B program grew by 24% in 2023, according to new figures from the government’s Health Resources and Services Administration. Sales at discounted prices
Skyrocketing 340B program spending must prompt more hospital accountability Read More »